Modus Operandi

» cancer and genetics & genomics

Most Recent

image: Massively Parallel Perturbations

Massively Parallel Perturbations

By | March 1, 2017

Scientists combine CRISPR gene editing with single-cell sequencing for genotype-phenotype screens.

0 Comments

A test tube-based genome-labeling technique has been brought under the microscope.

0 Comments

image: Wanted: Transcriptional Regulators

Wanted: Transcriptional Regulators

By | August 1, 2016

Researchers have designed a screen to find unique molecules, called riboswitches, that determine whether transcription will proceed.

0 Comments

image: A New Way to ID Targets of RNA-Binding Proteins

A New Way to ID Targets of RNA-Binding Proteins

By | July 1, 2016

The catalytic domain of an RNA-editing enzyme is fused with RNA-binding proteins.

0 Comments

image: Sensors for All

Sensors for All

By | May 1, 2016

A versatile modular strategy for detecting small molecules in eukaryotes

0 Comments

image: Tumor-Shrinking Triple-Helices

Tumor-Shrinking Triple-Helices

By | April 1, 2016

A braided structure and some adhesive hydrogel make therapeutic microRNAs both stable and sticky.

0 Comments

image: Gene Editing Without Foreign DNA

Gene Editing Without Foreign DNA

By | February 1, 2016

Scientists perform plant-genome modifications on crops without using plasmids.

0 Comments

image: Bursting Cancer’s Bubble

Bursting Cancer’s Bubble

By | April 1, 2015

Scientists make oxygen-filled microbubbles designed to increase tumor sensitivity to radiation.

3 Comments

image: Exit Strategy

Exit Strategy

By | January 1, 2014

Scientists come up with a better way to watch cells leave blood vessels.

0 Comments

image: BRET Meets FRET

BRET Meets FRET

By | May 1, 2013

Scientists create biocompatible, self-luminescing nanoparticles for in vivo imaging.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham